Beam Therapeutics Inc. (BEAM) Reports Q1 Loss, Misses Revenue Estimates — Negative

BEAM   Zacks Investment Research — May 06, 2025

Beam Therapeutics Inc. (BEAM) came out with a quarterly loss of $1.24 per share versus the Zacks Consensus Estimate of a loss of $1.11. This compares to loss of $1.21 per share a year ago.

image for news Beam Therapeutics Inc. (BEAM) Reports Q1 Loss, Misses Revenue Estimates

Archer Daniels Midland (ADM) Surpasses Q1 Earnings Estimates — Positive

ADM   Zacks Investment Research — May 06, 2025

Archer Daniels Midland (ADM) came out with quarterly earnings of $0.70 per share, beating the Zacks Consensus Estimate of $0.69 per share. This compares to earnings of $1.46 per share a year ago.

image for news Archer Daniels Midland (ADM) Surpasses Q1 Earnings Estimates

Dream Finders Homes Inc. (DFH) Q1 Earnings Lag Estimates — Negative

DFH   Zacks Investment Research — May 06, 2025

Dream Finders Homes Inc. (DFH) came out with quarterly earnings of $0.54 per share, missing the Zacks Consensus Estimate of $0.61 per share. This compares to earnings of $0.55 per share a year ago.

image for news Dream Finders Homes Inc. (DFH) Q1 Earnings Lag Estimates

EVgo Inc. (EVGO) Reports Q1 Loss, Tops Revenue Estimates — Negative

EVGO   Zacks Investment Research — May 06, 2025

EVgo Inc. (EVGO) came out with a quarterly loss of $0.09 per share versus the Zacks Consensus Estimate of a loss of $0.11. This compares to loss of $0.09 per share a year ago.

image for news EVgo Inc. (EVGO) Reports Q1 Loss, Tops Revenue Estimates

Neuronetics (STIM) Reports Q1 Loss, Tops Revenue Estimates — Negative

STIM   Zacks Investment Research — May 06, 2025

Neuronetics (STIM) came out with a quarterly loss of $0.21 per share versus the Zacks Consensus Estimate of a loss of $0.13. This compares to loss of $0.27 per share a year ago.

image for news Neuronetics (STIM) Reports Q1 Loss, Tops Revenue Estimates

TScan Therapeutics, Inc. (TCRX) Reports Q1 Loss, Tops Revenue Estimates — Negative

TCRX   Zacks Investment Research — May 06, 2025

TScan Therapeutics, Inc. (TCRX) came out with a quarterly loss of $0.26 per share versus the Zacks Consensus Estimate of a loss of $0.28. This compares to loss of $0.32 per share a year ago.

image for news TScan Therapeutics, Inc. (TCRX) Reports Q1 Loss, Tops Revenue Estimates

J&J Snack Foods (JJSF) Q2 Earnings and Revenues Lag Estimates — Negative

JJSF   Zacks Investment Research — May 06, 2025

J&J Snack Foods (JJSF) came out with quarterly earnings of $0.35 per share, missing the Zacks Consensus Estimate of $0.69 per share. This compares to earnings of $0.84 per share a year ago.

image for news J&J Snack Foods (JJSF) Q2 Earnings and Revenues Lag Estimates

Palantir Hits Another Home Run, But It's Just Not Enough — Positive

PLTR   Seeking Alpha — May 06, 2025

Palantir Technologies Inc.'s Q1 earnings report exceeded expectations, showcasing strong revenue growth, high bookings, expanding margins, and diversified customer base, solidifying its market leadership. Despite the bullish chart and primary uptrend, Palantir's valuation is unsustainable with a forward P/E of 212X and a PEG ratio near 9. PLTR stock's EV/sales ratio is 100X, far exceeding peers, indicating a significant overvaluation that cannot be justified by current growth rates.

image for news Palantir Hits Another Home Run, But It's Just Not Enough

Lemonade: Solid Growth in Tough Quarter — Neutral

LMND   The Motley Fool — May 06, 2025

Here's our initial take on Lemonade's (LMND -0.03%) fiscal 2025 first-quarter financial report.

image for news Lemonade: Solid Growth in Tough Quarter

FST Corp. Announces Managerial Appointments — Neutral

KBSX   GlobeNewsWire — May 06, 2025

BOULDER, CO, May 06, 2025 (GLOBE NEWSWIRE) -- FST Corp. (Nasdaq: KBSX), a leading manufacturer and marketer of steel and graphite golf shafts and a provider of other golf-related services, today announced that, on April 29, 2025, its board of directors made the following appointments to key managerial positions in the Company.

image for news FST Corp. Announces Managerial Appointments

Company continues to innovate and develop its SaaS-based platform to facilitate Rx-to-OTC switch in line with recent President Trump Executive Order NEW YORK, NY / ACCESS Newswire / May 6, 2025 / Petros Pharmaceuticals, Inc. (NASDAQ:PTPI) ("Petros" or the "Company"), a company focused on expanding consumer access to medication through over the counter ("OTC") drug development programs, today announces it has implemented multiple enhancements to its developing AI platform, which is expected to improve processing and fraud detection and provide a better overall experience. The AI Platform is expected to be a key component of the Company's recently announced SaaS-based …

image for news Petros Pharmaceuticals Strengthens Partnership with Market Leading Big Data Provider Implementing Key Enhancements to its AI Platform

DoorDash Inc (NYSE:DASH) had a £2.9 billion ($3.9 billion) offer for Deliveroo PLC (LSE:ROO) accepted but the San Francisco group's announcement had a telling omission, analysts said. An indicative offer of 180p per share, which was announced a week last Friday, was firmed up as a formal offer and the board has accepted on the same terms, the New York-listed company said on Tuesday.

image for news Deliveroo's largest shareholder Amazon 'most likely' to mount counterbid to DoorDash

DALLAS , May 6, 2025 /PRNewswire/ -- Kimberly-Clark Corporation (NYSE: KMB) today announced that Russ Torres, President, North America, has been promoted to President and Chief Operating Officer, effective immediately. As President and COO, Torres will be responsible for the day-to-day operations of Kimberly-Clark's business segments.

image for news Kimberly-Clark Promotes Russ Torres to President and Chief Operating Officer

Zoetis (ZTS) Surpasses Q1 Earnings and Revenue Estimates — Positive

ZTS   Zacks Investment Research — May 06, 2025

Zoetis (ZTS) came out with quarterly earnings of $1.48 per share, beating the Zacks Consensus Estimate of $1.40 per share. This compares to earnings of $1.38 per share a year ago.

image for news Zoetis (ZTS) Surpasses Q1 Earnings and Revenue Estimates

Viridian Therapeutics, Inc. (VRDN) Reports Q1 Loss, Lags Revenue Estimates — Negative

VRDN   Zacks Investment Research — May 06, 2025

Viridian Therapeutics, Inc. (VRDN) came out with a quarterly loss of $0.87 per share versus the Zacks Consensus Estimate of a loss of $0.95. This compares to loss of $0.79 per share a year ago.

image for news Viridian Therapeutics, Inc. (VRDN) Reports Q1 Loss, Lags Revenue Estimates

AdaptHealth Corp. (AHCO) Meets Q1 Earnings Estimates — Positive

AHCO   Zacks Investment Research — May 06, 2025

AdaptHealth Corp. (AHCO) came out with quarterly earnings of $0.01 per share, in line with the Zacks Consensus Estimate. This compares to earnings of $0.02 per share a year ago.

image for news AdaptHealth Corp. (AHCO) Meets Q1 Earnings Estimates

Colliers International (CIGI) Q1 Earnings and Revenues Miss Estimates — Negative

CIGI   Zacks Investment Research — May 06, 2025

Colliers International (CIGI) came out with quarterly earnings of $0.87 per share, missing the Zacks Consensus Estimate of $0.89 per share. This compares to earnings of $0.77 per share a year ago.

image for news Colliers International (CIGI) Q1 Earnings and Revenues Miss Estimates

DoorDash, Inc. (DASH) Q1 Earnings Beat Estimates — Positive

DASH   Zacks Investment Research — May 06, 2025

DoorDash, Inc. (DASH) came out with quarterly earnings of $0.44 per share, beating the Zacks Consensus Estimate of $0.40 per share. This compares to loss of $0.06 per share a year ago.

image for news DoorDash, Inc. (DASH) Q1 Earnings Beat Estimates

Datadog (DDOG) Surpasses Q1 Earnings and Revenue Estimates — Positive

DDOG   Zacks Investment Research — May 06, 2025

Datadog (DDOG) came out with quarterly earnings of $0.46 per share, beating the Zacks Consensus Estimate of $0.42 per share. This compares to earnings of $0.44 per share a year ago.

image for news Datadog (DDOG) Surpasses Q1 Earnings and Revenue Estimates

CCC Intelligent Solutions Holdings Inc. (CCCS) Meets Q1 Earnings Estimates — Positive

CCCS   Zacks Investment Research — May 06, 2025

CCC Intelligent Solutions Holdings Inc. (CCCS) came out with quarterly earnings of $0.08 per share, in line with the Zacks Consensus Estimate. This compares to earnings of $0.09 per share a year ago.

image for news CCC Intelligent Solutions Holdings Inc. (CCCS) Meets Q1 Earnings Estimates